| RS757230587 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Alagille syndrome due to a JAG1 point mutation |
| RS757230924 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS757231239 |
MSH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS757231565 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS757231578 |
FN1
|
Health Risk |
Conflicting classifications of pathogenicity |
FN1-related disorder, Inborn genetic diseases |
| RS757232346 |
SYNE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Emery-Dreifuss muscular dystrophy 5, autosomal dominant |
| RS757233170 |
EDAR
|
Health Risk |
Likely pathogenic |
Autosomal recessive hypohidrotic ectodermal dysplasia syndrome, Ectodermal dysplasia 10A |
| RS75723433 |
ABCA12
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital ichthyosis of skin, Congenital ichthyosis of skin |
| RS757237504 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS757238055 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS757239023 |
RYR3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epileptic encephalopathy, Epileptic encephalopathy |
| RS757240576 |
MAP2K2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, RASopathy |
| RS757240900 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS757241673 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS757242261 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 10, Arrhythmogenic right ventricular cardiomyopathy |
| RS757242487 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS757243984 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, KMT2D-related disorder |
| RS757243985 |
FREM2
|
Health Risk |
Likely pathogenic |
— |
| RS757244518 |
SLC4A11
|
Health Risk |
Pathogenic |
Corneal dystrophy-perceptive deafness syndrome, Corneal dystrophy-perceptive deafness syndrome |
| RS757245615 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS757246221 |
GPR179
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS757247313 |
PALM
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS757247849 |
PRX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4F, Charcot-Marie-Tooth disease type 4 |
| RS757248672 |
SYNE4
|
Health Risk |
Pathogenic |
— |
| RS757249400 |
RARS1
|
Health Risk |
Likely pathogenic |
— |
| RS757249676 |
MAEL
|
Health Risk |
Likely pathogenic |
Male infertility, Male infertility |
| RS757250956 |
MLC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts 1 |
| RS757251412 |
COQ9
|
Health Risk |
Conflicting classifications of pathogenicity |
Encephalopathy-hypertrophic cardiomyopathy-renal tubular disease syndrome, Inborn genetic diseases |
| RS757251437 |
MTMR14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant centronuclear myopathy, Autosomal dominant centronuclear myopathy |
| RS757251877 |
LAMB2
|
Health Risk |
Likely pathogenic |
LAMB2-related infantile-onset nephrotic syndrome, LAMB2-related infantile-onset nephrotic syndrome |
| RS757252110 |
LDLR
|
Health Risk |
Pathogenic |
Hypercholesterolemia, familial |
| RS757252384 |
EYA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1J, Autosomal dominant nonsyndromic hearing loss 10 |
| RS757252494 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS757252832 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS757252849 |
GBA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 46, Neurodevelopmental disorder |
| RS757252885 |
ASPM
|
Health Risk |
Pathogenic |
ASPM-related disorder, ASPM-related disorder |
| RS757253624 |
IFT172
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS757253926 |
TWIST1
|
Health Risk |
Pathogenic |
Saethre-Chotzen syndrome, TWIST1-related craniosynostosis |
| RS757254927 |
GLDC
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycine encephalopathy, Glycine encephalopathy |
| RS757255802 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS757256051 |
GLB1
|
Health Risk |
Likely pathogenic |
GM1 gangliosidosis, Mucopolysaccharidosis |
| RS757256314 |
AP3B2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS757259023 |
PARD3
|
Health Risk |
risk factor |
Neural tube defect, Neural tube defect |
| RS757259401 |
LMOD3
|
Health Risk |
Pathogenic |
— |
| RS757259413 |
ELP4;PAX6
|
Health Risk |
Pathogenic/Likely pathogenic |
Aniridia 1, Irido-corneo-trabecular dysgenesis |
| RS757260058 |
SIGMAR1
|
Health Risk |
Likely pathogenic |
Amyotrophic lateral sclerosis type 16, Autosomal recessive distal spinal muscular atrophy 2 |
| RS757260904 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS757261031 |
CDH23
|
Health Risk |
Likely pathogenic |
Pituitary adenoma 5, multiple types |
| RS757261714 |
RAD50
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Nijmegen breakage syndrome-like disorder |
| RS757261752 |
IVD
|
Health Risk |
Likely pathogenic |
— |
| RS757264014 |
BRAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neonatal-onset encephalopathy with rigidity and seizures, Inborn genetic diseases |
| RS757264206 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stiff skin syndrome, Acromicric dysplasia |
| RS757264535 |
ANKRD11
|
Health Risk |
Conflicting classifications of pathogenicity |
KBG syndrome, Inborn genetic diseases |
| RS757264957 |
KIF7
|
Health Risk |
Conflicting classifications of pathogenicity |
Acrocallosal syndrome, Inborn genetic diseases |
| RS757265256 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS757266656 |
GCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinism due to glucokinase deficiency, Permanent neonatal diabetes mellitus |
| RS757267294 |
NHLRC2
|
Health Risk |
Pathogenic |
Fibrosis, neurodegeneration |
| RS757267575 |
BMP1
|
Health Risk |
Pathogenic |
— |
| RS757268030 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS757268536 |
PTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Gorlin syndrome, Hereditary cancer-predisposing syndrome |
| RS757268664 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS757274362 |
ATP2A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Brody myopathy, Brody myopathy |
| RS757274577 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS757274881 |
TP53
|
Health Risk |
Pathogenic |
Ovarian neoplasm, Li-Fraumeni syndrome |
| RS757275103 |
RB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinoblastoma, Malignant tumor of urinary bladder |
| RS757275351 |
DNAH5
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS757275646 |
F11
|
Health Risk |
Likely pathogenic |
— |
| RS757275923 |
DLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS757276241 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS757276569 |
DOCK8
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS757277027 |
FAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS757277769 |
POLR3A
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukodystrophy, hypomyelinating |
| RS757278862 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS757279881 |
CRB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Leber congenital amaurosis 8, Retinitis pigmentosa 12 |
| RS757280513 |
SYNE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive ataxia, Beauce type |
| RS757280832 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, Hypogonadotropic hypogonadism 5 with or without anosmia |
| RS757281286 |
GCK
|
Health Risk |
Likely pathogenic |
Monogenic diabetes, Monogenic diabetes |
| RS757281872 |
CABP2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS757282598 |
RBBP8
|
Health Risk |
Conflicting classifications of pathogenicity |
Jawad syndrome, Seckel syndrome 2 |
| RS757282628 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1 |
| RS757283184 |
HMOX1
|
Health Risk |
Likely pathogenic |
— |
| RS757286692 |
TRPM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial heart block type IB, Cardiovascular phenotype |
| RS757286784 |
OCA2
|
Health Risk |
Likely pathogenic |
Tyrosinase-positive oculocutaneous albinism, SKIN/HAIR/EYE PIGMENTATION 1 |
| RS757289680 |
SLC16A2
|
Health Risk |
Likely pathogenic |
— |
| RS757290084 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Dystrophin deficiency |
| RS757290350 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS757290764 |
TBX1
|
Health Risk |
Conflicting classifications of pathogenicity |
DiGeorge syndrome, Tetralogy of Fallot |
| RS757291476 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 42 |
| RS757291528 |
TYRP1
|
Health Risk |
Pathogenic |
— |
| RS757292066 |
NKX2-6
|
Health Risk |
Likely pathogenic; risk factor |
Conotruncal heart malformations, Cerebral palsy |
| RS757294519 |
WDR62
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 2, primary |
| RS757294568 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Hereditary cancer-predisposing syndrome |
| RS757294772 |
SCN10A
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome, Cardiovascular phenotype |
| RS757295540 |
AARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS757297254 |
GBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type IV |
| RS757299093 |
CYP11A1
|
Health Risk |
Pathogenic |
Congenital adrenal insufficiency with 46, XY sex reversal OR 46 |
| RS757299200 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic generalized epilepsy, Hyperaldosteronism |
| RS757299831 |
SPINK5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS757300247 |
SMCHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS757300563 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
— |